Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Florida International University
With
City University of New York
National Institute on Drug Abuse (NIDA)
In Stage 1, participants will be randomized to receive either: 1) three months of CM; or 2) two sessions of MI. All participants will be assessed at three months post-randomization for non-response. In Stage 2, a second randomization where non-responders (i.e., those who have not filled a PrEP prescription) are assigned to: 1) Switch to sequentially receive the other intervention (i.e., CM+MI or MI+CM); or 2) Continue with assessments only (i.e., CM-Only or MI-Only). All participants will complete a final assessment at 6 months.
Age
18–any
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
At least 18 years of age
Sexually active cisgender sexual minority man
Reports using stimulants in the past three months
HIV-negative serostatus
Meets Centers for Disease Control and Prevention (CDC) criteria for PrEP eligibility
You may not be if
Currently prescribed PrEP
Unable to provide informed consent
Severe psychiatric symptoms (e.g., mania, psychosis) that impair capacity to participate